⁢ ⁢ The United Kingdom is introducing a national chickenpox vaccination program for children, marking⁢ a significant step in public health protection. The rollout, announced⁢ by NHS England, aims to shield young people‍ from the⁢ highly contagious varicella-zoster virus, which ⁢causes chickenpox.

Program Details and Eligibility

The ‍program ⁤will be rolled out in phases, beginning with children in school Year 1 (aged 5-6). According to NHS England, the vaccine will be offered to all one-year-olds by spring ⁤2024. ⁤ The⁣ eligibility criteria are based on date ⁢of⁢ birth, ensuring a systematic approach to vaccination.
‍

⁤ ‍ Dr. Claire Fuller,National Medical Director of NHS England,hailed ⁢the program as a “major win for children and families,” ⁤emphasizing the vaccine’s protective benefits. She stated the ⁣vaccine will “enable more children to stay safely in school,” minimizing disruption caused by the disease (Business AM).
⁢

The chickenpox vaccine is a two-dose vaccine, administered as part of the routine childhood‍ immunization schedule.

Effectiveness and Safety of‍ the Chickenpox Vaccine

⁣ ⁤ The chickenpox vaccine is highly effective in preventing the disease. Studies have shown that two ⁢doses of the vaccine ‍are 98% effective at‍ preventing chickenpox. Even if a vaccinated person does contract chickenpox, the⁢ symptoms are typically milder than in unvaccinated individuals (Centers ⁢for Disease ⁤Control and Prevention).

The vaccine has a strong ⁣safety profile,‍ with most side effects being mild, such as soreness at the injection site or a mild rash. Serious side effects are rare.Countries with long-standing ‍chickenpox vaccination programs, such as the United States and Germany, have demonstrated significant reductions ⁢in chickenpox cases and ⁤related complications.

source: Data⁣ compiled from the CDC and Robert Koch Institute (Germany).UK data ⁣represents pre-vaccination rates.
⁣